CXCL12 and primitive neuroectodermal tumor: Notably, interventions targeting the CXCR4–SDF1 axis, such as siSDF1, siCXCR4, or antibodies, can downregulate the expression of AGR2, thus suppressing the growth and metastatic potential of PNET cells.